Metraipolis › archive › dc_cd633a00f9d2
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41598485
- DOI
- 10.3390/jcm15020547
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:28:19.118Z
- SHA-256 of the archived text
0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781- Stable URL of this page
https://metraipolis.com/documento/dc_cd633a00f9d2
How to cite
Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485 — Europe PMC (en), https://europepmc.org/article/MED/41598485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd633a00f9d2 (Metraipolis archive dc_cd633a00f9d2, sha256 0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781)
BibTeX
@misc{dccd633a00f9d2,
title = {Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease — Europe PMC PMID:41598485},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41598485},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd633a00f9d2; sha256 0773ae29ff277d806e32cabfb958d47a5ca7d291dfa1de7e505cbecf34bc4781},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598485. Agents can read the archived copy with the MCP tool read_document.